For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Free the Economy podcast: Paying for organs with Pete Jaworski
In this week’s episode we cover the future of AI and employment, why we shouldn’t trust Chinese economic statistics, and how the…
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
Blog
This week in ridiculous regulations: Taconite and lab fees
President Biden delivered his State of the Union address. Super Tuesday primaries all but settled this year’s presidential combatants. The FTC has a full slate…
Search Posts
Op-Eds
Weed Control has Caused Skylark’s Decline (Letter to the Editor)
From Mr Gregory Conko. Sir, Your article “Bird numbers `under threat’ from GM crops” (September 1) reported on a study in the current issue of…
Op-Eds
Effects of GM Confused with Those of Farming Practices: Conko Letter to Financial Times
Published in The Financial Times Published in The Financial Times September 6, 2000, Wednesday London Edition 1 …
Products
Throwing Precaution to the Wind: The Perils of the Precautionary Principle
From the August/September issue of CEI UpDate Mom always said, “Better safe than sorry.” Dad, on the other hand, believed…
Op-Eds
Resistance Dropping Toward Biotech Foods
In spite of an ill-considered, anti-progress publicity campaign from left wing self-appointed consumer and environmental groups, the New Green Revolution based on genetic engineering is…
Op-Eds
Resistance Dropping to Biotech Foods: Kemp Op-Ed in Chicago Tribune
Published in the Chicago Tribune Published in the Chicago Tribune August 25, 2000 In spite of an ill-considered,…
Op-Eds
Canada Misses a Fat Chance: Henry Miller Op-Ed in the National Post
Published in the National Post (Canada) July 25, 2000 Canadian regulators’ decision to ban the fat substitute olestra runs against both…